• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Study: Propeller’s Smart Inhaler for Asthma Management Improves Patient Satisfaction

by Jasmine Pennic 06/07/2018 Leave a Comment

Study: Propeller's Smart Inhaler for Asthma Management Improves Patient Satisfaction

A new peer-reviewed study published in the Journal of Medical Internet Research mHealth and uHealth demonstrated high levels of patient satisfaction with Propeller Health’s smart inhaler for asthma management. Although digital health tools are increasingly recognized as effective in improving clinical outcomes such as asthma control and medication adherence, few studies have assessed patient experiences and perception of value.

“I was never sure how often I used my rescue inhaler. When my doctor asked, I could not give him an accurate response, and now I can,” reported one study participant.

The goal peer-reviewed study to evaluate patient satisfaction, perception of usability and value, and desire to continue after 12 months of using a digital health intervention to support asthma management.

Study Overview

Participants were enrolled in a randomized controlled study evaluating the impact of a digital health platform for asthma management. Participants used Propeller’s FDA-cleared digital medicine for asthma to track medication use and accessed their information. Propeller sends medication reminders and reports on when, where and why a patient might be experiencing symptoms based on their use of rescue medications.

Electronic surveys were administered to intervention arm participants aged 12 years and older after 12 months of use. The survey focused on asthma control, patient satisfaction with the sensor device, and perception of the usability and value of the digital health platform through closed-ended and open-ended questions.

Key Findings/Results

Overall, 79 percent of the respondents were “very satisfied” and 20 percent were “somewhat satisfied” with the Propeller system. The study also found that 93 percent of respondents expressed satisfaction with the reports from Propeller detailing when, where, and why they might be experiencing asthma symptoms. 72 percent of respondents reported interest in continuing to use the Propeller system beyond the trial, which took place from 2012 to 2014 at Dignity Health.

“I have used Propeller for more than five years now in my clinical practice, and it has changed how I care for my patients,” said Dr. Rajan Merchant, a specialist in allergy, asthma and immunology medicine with Dignity Health and lead author of the study. “It allows me to have real conversations with my patients, tailor their therapy, and focus on the patients that need the most attention. It makes me and our clinic staff more effective at and satisfied with our jobs, which results in more satisfied patients.”

Tagged With: Asthma, Propeller Health, Smart Inhaler

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |